Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-15 Sale | 2023-12-19 4:15 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 17,135 | $407 | $6,973,945 | 110,276 (Direct) | View |
| 2023-12-13 Sale | 2023-12-15 4:23 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 5,098 | $397 | $2,023,906 | 108,711 (Direct) | View |
| 2023-11-13 Sale | 2023-11-15 4:16 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 5,097 | $377 | $1,921,569 | 113,809 (Direct) | View |
| 2023-07-17 Sale | 2023-07-18 4:13 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 7,828 | $355 | $2,778,940 | 118,906 (Direct) | View |
| 2023-04-27 Sale | 2023-05-01 4:26 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 3,317 | $339.08 | $1,124,726 | 126,652 (Direct) | View |
| 2023-01-25 Sale | 2023-01-27 4:13 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 10,000 | $315.05 | $3,150,500 | 89,598 (Direct) | View |
| 2022-08-15 Sale | 2022-08-17 5:40 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 11,689 | $305.06 | $3,565,846 | 99,598 (Direct) | View |
| 2022-06-24 Sale | 2022-06-28 4:05 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 11,689 | $291.3 | $3,405,006 | 111,153 (Direct) | View |
| 2021-08-19 Purchase | 2021-08-23 08:30 am | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 10,000 | $195.65 | $1,956,492 | 73,754 (Direct) | View |
| 2020-08-06 Sale | 2020-08-10 4:19 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 2,073 | $271.2 | $562,205 | 45,326 (Direct) | View |
| 2020-05-15 Sale | 2020-05-19 4:35 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 99 | $284.17 | $28,132 | 26,626 (Direct) | View |
| 2020-05-06 Sale | 2020-05-08 4:19 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 2,074 | $272.85 | $565,882 | 47,399 (Direct) | View |
| 2020-02-25 Sale | 2020-02-26 4:32 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 3,634 | $233.45 | $848,371 | 26,626 (Direct) | View |
| 2020-02-18 Sale | 2020-02-19 4:33 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 1,183 | $243.51 | $288,070 | 33,158 (Direct) | View |
| 2020-02-06 Sale | 2020-02-07 4:14 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 2,074 | $239.44 | $496,600 | 58,132 (Direct) | View |
| 2019-11-25 Sale | 2019-11-26 4:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 4,692 | $219.37 | $1,029,284 | 33,432 (Direct) | View |
| 2019-11-15 Sale | 2019-11-19 4:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 61 | $205.95 | $12,563 | 13,098 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-23 Tax Withholding | 2024-02-27 4:55 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 9,386 | $431.79 | 136,507 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-21 4:29 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 9,359 | $424.01 | 145,893 (Direct) | View |
| 2024-02-20 Tax Withholding | 2024-02-21 4:29 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 7,019 | $420.58 | 145,893 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 8,255 | $422.74 | 162,271 (Direct) | View |
| 2024-02-06 Option Award | 2024-02-08 4:38 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 61,815 | $0 | 170,526 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-19 4:15 pm | N/A 2028-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 17,135 | $0 | 110,276 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-19 4:15 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 14,077 | $187.53 | 110,276 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-19 4:15 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 3,058 | $155.57 | 110,276 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:07 pm | N/A N/A | Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director | 245,123 | $0 | 245,123 (Direct) | View |
| 2023-02-24 Tax Withholding | 2023-02-28 4:53 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 9,386 | $289.12 | 129,969 (Direct) | View |
| 2023-02-17 Tax Withholding | 2023-02-22 4:35 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 9,359 | $292.85 | 139,355 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 4:58 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 3,372 | $294.33 | 148,714 (Direct) | View |
| 2023-02-13 Tax Withholding | 2023-02-14 4:58 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 5,990 | $298.26 | 148,714 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 68,478 | $0 | 158,076 (Direct) | View |
| 2022-09-30 Exercise | 2022-11-10 5:30 pm | N/A N/A | Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director | 9,818 | $0 | 80,739 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 9:12 pm | N/A 2032-06-10 | Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director | 179,437 | $0 | 179,437 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-02-28 5:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 7,246 | $227.86 | 122,842 (Direct) | View |
| 2022-02-17 Tax Withholding | 2022-02-22 4:56 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 8,584 | $232.51 | 130,088 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-14 4:16 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 3,031 | $237.74 | 138,672 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:17 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 67,949 | $0 | 141,703 (Direct) | View |
| 2021-11-19 Option Award | 2021-11-23 5:00 pm | N/A N/A | Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director | 9,818 | $0 | 9,818 (Direct) | View |
| 2021-09-16 Option Award | 2021-09-20 9:51 pm | N/A 2031-09-15 | Ginkgo Bioworks Holdings Inc. | DNA | Kewalramani Reshma Director | 69,431 | $0 | 69,431 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 4:15 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 2,898 | $217.57 | 63,643 (Direct) | View |
| 2021-02-17 Tax Withholding | 2021-02-19 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 2,080 | $211.75 | 66,541 (Direct) | View |
| 2021-02-10 Tax Withholding | 2021-02-12 4:07 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 2,962 | $214.16 | 68,621 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 44,935 | $0 | 71,583 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:19 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 2,073 | $0 | 45,326 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 1,564 | $187.53 | 45,326 (Direct) | View |
| 2020-08-06 Exercise | 2020-08-10 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 509 | $155.57 | 45,326 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:19 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 2,074 | $0 | 47,399 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 1,564 | $187.53 | 47,399 (Direct) | View |
| 2020-05-06 Exercise | 2020-05-08 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 510 | $155.57 | 47,399 (Direct) | View |
| 2020-02-24 Tax Withholding | 2020-02-26 4:32 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 2,898 | $239.23 | 26,626 (Direct) | View |
| 2020-02-17 Tax Withholding | 2020-02-19 4:33 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 944 | $241.5 | 33,158 (Direct) | View |
| 2020-02-05 Option Award | 2020-02-07 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 22,187 | $0 | 58,132 (Direct) | View |
| 2020-02-06 Exercise | 2020-02-07 4:14 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 2,074 | $0 | 58,132 (Direct) | View |
| 2020-02-06 Exercise | 2020-02-07 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 1,564 | $187.53 | 58,132 (Direct) | View |
| 2020-02-06 Exercise | 2020-02-07 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 510 | $155.57 | 58,132 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-26 4:12 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 4,692 | $0 | 33,432 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-26 4:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO | 4,692 | $187.53 | 33,432 (Direct) | View |